I. Introduction
===============

The basement membrane (BM) is a specialized, 50- to 100-nm thick, extracellular matrix that surrounds every cell cord including endothelial cells. It has a role in the structural support and barriers of tissues, and in the proliferation, adhesion, migration, and differentiation of cells. There are 4 major components of BM: laminin, type IV collagen, nidogen, and heparan-sulphate proteoglycan core protein \[[@B1], [@B2], [@B25]\]. Laminin is required for BM assembly, as the N-terminal (domain VI) of laminin promotes laminin polymerization \[[@B1], [@B2], [@B17]\]. Laminin is also important in regulating cellular behavior and function through its interaction with cell surface receptors such as integrin and dystroglycan \[[@B5], [@B15], [@B17]\].

Laminin is a cross-shaped heterotrimeric glycoprotein comprising single α, β, and γ chains \[[@B2]\]. The three chains form a complex by disulfide bounds, and the complex is secreted as matrices after glycosylation. Thus far, research has identified 5 α, 3 β, and 3 γ chains. By combining into heterotrimers, they assemble to form 19 different laminin isoforms (eg, laminin 111 comprises the α1, β1, and γ1 chains) \[[@B5]\]. Each laminin isoform is synthesized by numerous cell types and has distinct signals in a variety of tissues \[[@B8]\]. For instance, laminin 111 induces cell differentiation in mammary gland cells \[[@B21]\], while laminin 411 mediates adhesion and migration of platelets, leukocytes, and vascular endothelial cells \[[@B6]\]. Thus, laminin isoforms must be identified so as to reveal their functional roles.

In contrast to other tissues, the specific laminin isoforms expressed in the anterior pituitary have not been identified, although several studies have confirmed the presence of laminin protein in this gland \[[@B10], [@B11], [@B13], [@B19]\]. In the present study, we used RT-PCR to identify laminin chains expressed in the anterior pituitary. In addition, we used immunohistochemistry and *in situ* hybridization to identify laminin isoforms and laminin-producing cells.

II. Materials and Methods
=========================

Animals
-------

Wistar rats were purchased from Japan SLC (Shizuoka, Japan). Transgenic S100β-GFP rats, which express GFP in FS cells under the control of exogenous S100β protein gene promoter, were kindly donated by Prof. K. Inoue of Saitama University and bred in our animal facility \[[@B12]\]. Animals were given conventional food and water *ad libitum* and were kept under a 12 hr light/12 hr dark cycle. All animal experiments were performed after receiving approval from the Institutional Animal Experiment Committee of the Jichi Medical University and were conducted in accordance with the Institutional Regulations for Animal Experiments and Fundamental Guideline for Proper Conduct of Animal Experiments and Related Activities in Academic Research Institutions, under the jurisdiction of the Japanese Ministry of Education, Culture, Sports, Science and Technology.

Tissue preparation
------------------

Animals (postnatal day 60) weighing 250--300 g were deeply anesthetized intraperitoneally with pentobarbital sodium (Kyoritsu Seiyaku, Tokyo, Japan). A solution of 4% paraformaldehyde in 0.05 M phosphate buffer (PB), pH 7.4, was perfused through the left ventricle. Pituitaries were dissected out and immersed overnight in the same fixative at 4°C. The tissues were transferred into 30% sucrose in 0.05 M PB buffer, pH 7.2, at 4°C for 2 days. The tissues were then embedded in Tissue-Tek compound (Sakura Finetechnical, Tokyo, Japan) and frozen rapidly. A cryostat (CM3000; Leica Microsystems, Wetzlar, Germany) was used to make frontal sections (8 µm), which were used for immunohistochemistry and *in situ* hybridization.

Reverse transcription-polymerase chain reaction (RT-PCR)
--------------------------------------------------------

Anterior pituitaries were dissected and rapidly immersed in liquid nitrogen. Trizol RNA extraction (Qiagen, Hilden, Germany) and subsequent RNase-free DNase I treatment (Promega, Madison, WI, USA) were performed to extract total RNA according to the manufacturer's instructions. cDNA was made by using the SuperScript III Reverse Transcriptase kit with oligo-d(T)~20~ primer (Life Technologies, CA, USA). Gene expression of laminin chains was determined by PCR using specific primers (Table [1](#T1){ref-type="table"}). The expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control.

Immunofluorescence
------------------

Immunofluorescence was performed as previously described with some modifications \[[@B7]\]. Briefly, sections were heat-retrieved with 0.01 M citrate buffer, pH 6.0, in 90°C for 10 min \[[@B16]\]. The sections were then incubated in primary antibodies (Table [2](#T2){ref-type="table"}) for 90 min at 30°C. If necessary, biotinylated isolectin B4 (B-1205; Vector Laboratories, CA, USA), which binds to galactose residue on the surface of endothelial cells \[[@B3]\], was added to the primary antibodies to detect endothelial cells. The sections were then incubated in secondary antibodies, namely, Alexa Fluor 488-conjugated goat anti-rabbit IgG (1:200) and Alexa Fluor 568-conjugated goat anti-rabbit IgG (1:200) (Life Technologies). Biotinylated isolectin B4 was detected by Alexa Fluor 488-conjugated streptavidin (1:400) or Alexa Fluor 568-conjugated streptavidin (1:400) (Life Technologies). Sections were scanned using a confocal laser microscope (FV1000; Olympus, Tokyo, Japan).

In situ hybridization
---------------------

Because suitable commercial anti-laminin β- and γ-chain antibodies for immunohistochemistry could not be obtained, we used *in situ* hybridization to determine the localization of the laminin β and γ chains. *In situ* hybridization was performed as described previously \[[@B7]\]. Briefly, to make complementary RNA (cRNA), DNA fragments were amplified from cDNA of adult rat pituitary, using gene-specific primers (Table [1](#T1){ref-type="table"}). DNA fragments were ligated into the pGEM-T vector (Promega) and cloned. Gene-specific antisense or sense digoxigenin (DIG)-labeled cRNA probes were made by using a Roche DIG RNA labeling kit (Roche Diagnostics, Penzberg, Germany). DIG-labeled cRNA probe hybridization was performed at 55°C for 16--18 hr. Each type of mRNA was visualized with alkaline phosphatase-conjugated anti-DIG antibody (Roche Diagnostics) by using 4-nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phosphate (Roche Diagnostics). Sections treated with DIG-labeled sense RNA probes were used as negative control.

The *in situ* hybridization sections were then immunohistochemically stained as described previously \[[@B7]\]. Briefly, the sections were incubated with rabbit polyclonal anti-luteinizing hormone β antibody or biotinylated isolectin B4 (an endothelial cell marker) for 90 min at 30°C (for details, see Table [2](#T2){ref-type="table"}). The immunoreactive signal was detected by using a Vecstain ABC kit (Vector Laboratories) and 3,3\'-diaminobenzidine (Dojindo Laboratories, Kumamoto, Japan). Stained sections were observed using an AX-80 microscope (Olympus).

III. Results
============

Immunohistochemistry of laminin and isolectin B4
------------------------------------------------

To localize laminin deposition in anterior pituitary gland, pituitary sections were stained using anti-laminin antibody (LSL-LB-1013), which recognizes native form laminin protein and is not laminin chain-specific antibody (Fig. [1](#F1){ref-type="fig"}a). To observe vascular localization, we also stained endothelial cells with biotinylated isolectin B4. Capillary walls stained by isolectin B4 were distributed throughout the anterior pituitary (Fig. [1](#F1){ref-type="fig"}b). Laminin was deposited beneath the capillaries (vascular basement membrane) and interstitial spaces of the anterior pituitary (Fig. [1](#F1){ref-type="fig"}a--d). Laminin was also observed in the cytoplasm of some pituitary cells (Fig. [1](#F1){ref-type="fig"}a--d).

Expression of laminin chains
----------------------------

Expression of laminin chains in the anterior pituitary was determined by RT-PCR. Laminin α1, α3, α4, β1, β2, and γ1 were expressed, while laminin α2, α5, β3, γ2, γ3 were weakly expressed (Fig. [2](#F2){ref-type="fig"}).

Because transcripts of laminin α1, α3, and α4 chains were detected in the gland, we stained these chains using α chain-specific antibodies. Laminin α1 was detected only in the cytoplasm of some pituitary cells; it was not colocalized with isolectin B4 (Fig. [3](#F3){ref-type="fig"}a--d). Strong immunostaining of both laminin α3 and laminin α4 was detected only in endothelial cells. Laminin α3 staining showed a punctate pattern in cytoplasm and the cell membrane, and its distribution was very limited (Fig. [3](#F3){ref-type="fig"}e--h). In comparison, laminin α4 staining was diffuse in endothelial cell cytoplasm and some endothelial cell membranes, and almost all endothelial cells were stained with laminin α4 (Fig. [3](#F3){ref-type="fig"}i--l).

To characterize the cells that produced laminin α1, laminin α1-immunopositive cells were detected by hormones and S100β (a marker of folliculo-stellate cells). Laminin α1-immunopositive cells were colocalized only with LHβ-immunopositive cells (gonadotrophs) (Fig. [4](#F4){ref-type="fig"}a--g).

We performed *in situ* hybridization of laminin β and γ chains to identify the laminin isoforms expressed in gonadotrophs and endothelial cells. Laminin β1, β2, and γ1 were expressed in gonadotrophs (Fig. [5](#F5){ref-type="fig"}a--c), and laminin β1 and γ1 were expressed in isolectin B4-positive cells (endothelial cells) (Fig. [5](#F5){ref-type="fig"}d--f).

IV. Discussion
==============

In this study, we used molecular biological and histochemical approaches to identify laminin chains and isoforms present in rat anterior pituitary. We found that gonadotrophs produce two types of laminin isoforms (laminin 111 and 121), as do endothelial cells (laminin 411 and 311).

The present study using anti-laminin antibody (LSL-LB-1013) showed laminin deposition in the vascular basement membrane, interstitial space, and a subset of pituitary cells (Fig. [1](#F1){ref-type="fig"}). These results accord with previous *in vivo* and *in vitro* experiments, which confirmed laminin immunolocalization in both the vascular basement membrane and some glandular cells of the anterior pituitary \[[@B9], [@B10], [@B22], [@B25]\]. Here, we successfully identified laminin α1, α3, α4, β1, β2, and γ1 in adult anterior pituitary (Fig. [2](#F2){ref-type="fig"}). Thus, the possible laminin isoforms expressed in this gland are laminin 111, 121, 311, 321, 411, and 421. We were also able to detect weak expression of laminin α2, α5, β3, γ2, and γ3 by RT-PCR, which suggests that laminin 211, 221, 212, 222, 213, 511, 521, 522, and 523 are also expressed in rat anterior pituitary, although expression levels might be very low.

The present study showed that the staining pattern for anti-laminin antibody (LSL-LB-1013) differed from that of anti-laminin α3 and α4 antibodies; the former stained the vascular basement membrane and the latter stained cytoplasm of endothelial cells (Figs. [1](#F1){ref-type="fig"} and [3](#F3){ref-type="fig"}). This is probably due to the epitope of the antibodies: anti-laminin antibody (LSL-LB-1013) can recognize mature and assembled laminin isoforms \[[@B23]\], while the α chain-specific antibodies recognize only the unassembled laminin α chain, which is normally present in cytoplasm \[[@B14]\].

We also revealed that the only laminin-producing cells in the anterior pituitary were gonadotrophs and endothelial cells (Figs. 3--5). In contrast, Vila-Porcile *et al.* (1987) reported that laminin was localized in gonadotrophs, thyrotropes, and corticotropes and was scarce in lactotrophs \[[@B24]\]. Although the present results were not consistent with their findings, it should be noted that we examined expression levels of laminin α, β, and γ chains by using multiple approaches, including RT-PCR, immunohistochemistry and *in situ* hybridization, and laminin chain-specific gene probes and antibodies. We found that gonadotrophs produced laminin 111 and 121, while endothelial cells produced laminin 411 and a very limited amount of laminin 311 in the anterior pituitary.

The expression of laminin isoforms is cell- and tissue-specific, and these isoforms are believed to have varying functions in different tissues \[[@B8]\]. For instance, laminin 111, which was found to be expressed in gonadotrophs in the present study, induces cell differentiation in mammary gland cells \[[@B21]\] and supports neurite outgrowth in human mesenchymal stem cells \[[@B18]\]. Laminin 121 also affects neurite outgrowth \[[@B20]\], while laminin 311 transmits mechanosignals in lung epithelial cells \[[@B4]\]. It is widely believed that laminin 411, which was found to be produced by endothelial cells in the present study, mediates adhesion of platelets, leukocytes, and vascular endothelial cells \[[@B6]\]. Although further studies are required in order to reveal the specific function of each laminin isoform in the anterior pituitary, specific laminin isoforms may potentially have distinct roles in the anterior pituitary: laminin 111 might induce cell differentiation, for example, while laminin 411 may act specifically on vascular cell movement.

In conclusion, the present study is the first to identify the laminin isoforms and laminin-producing cells in the anterior pituitary. The present findings will improve understanding of the roles of laminin and the molecular basis of its involvement in regulating pituitary function.
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![Distribution of laminin and endothelial cells in rat anterior pituitary. Immunofluorescence of anti-laminin antibody (LSL-LB-1013) and biotinylated isolectin B4 (an endothelial cell marker) are seen in **a** and **b**, respectively. A merged image is shown in **c** (laminin, green; isolectin B4, red). Bars=100 µm. Higher magnification of the merged image (arrowhead area in **c**) is shown in **d**. Bar=10 µm. Laminin protein was expressed in the vascular basement membrane, interstitial spaces, and a subset of pituitary cells.](AHC12028f01){#F1}

![Gene expression of laminin chains as determined by RT-PCR. The total mRNA fraction extracted from rat anterior pituitary was analyzed using laminin chain-specific primers. Laminin α1, α3, α4, β1, β2, and γ1 were expressed in the anterior pituitary.](AHC12028f02){#F2}

![Localization of laminin α chains in rat anterior pituitary. Immunofluorescence of laminin α1, α3, and α4 are shown in **a**, **e**, and **i**, respectively. Biotinylated isolectin B4 (**b, f, j**) was used as an endothelial cell marker. Merged images are shown in **c**, **g**, and **k** (laminin chains, green; isolectin B4, red; DAPI, blue; colocalization, yellow). Bar=50 µm. Higher magnification views of the merged images (arrowheads in **c, g, k**) are shown in **d**, **h**, and **l**. Bar=10 µm. DAPI was used as a nucleus marker. Laminin α1 was detected in a subset of pituitary cells. Laminin α3 deposition was observed in endothelial cells, although its distribution was very limited. Laminin α4 was detected in almost all endothelial cells.](AHC12028f03){#F3}

![Laminin α1-positive cells in rat anterior pituitary. Immunofluorescence of laminin α1 (green) and anterior pituitary hormones, pericytes, and endothelial cells (red). Anti-LHβ (**a**), GH (**b**), TSHβ (**c**), PRL (**d**), and 17-39-ACTH (**e**) antibodies were used to detect hormone-producing cells, and anti-desmin antibody was used to detect pericytes (**f**). The anterior pituitary of transgenic S100β-GFP rats was used to identify folliculo-stellate (FS) cells (**g**). Laminin α1 was colocalized only with LHβ-positive cells (gonadotrophs). Bar=10 µm.](AHC12028f04){#F4}

![Identification of laminin β and γ chains in rat anterior pituitary. *In situ* hybridization for laminin β1 (**a, d**), β2 (**b, e**), and γ1 (**c, f**), followed by immunohistochemistry for LHβ (**a--c**) or isolectin B4 (**d--f**). Cells expressing laminin β1, β2, and γ1 are shown in purple, and gonadotrophs and endothelial cells are in brown. All laminin β1, β2, and γ1 chains were expressed in gonadotrophs, while laminin β1 and γ1 chains were expressed in endothelial cells. Bar=10 µm.](AHC12028f05){#F5}

###### 

Primers for RT-PCR/cRNA probes

  No   Primer                Forward sequence (5\'-3\')   Reverse sequence (5\'-3\')   
  ---- --------------------- ---------------------------- ---------------------------- ----------------------
  1    laminin α1 (594 bp)   GenBank: NM_001108237        CGTCATGCAGATGTCCAAAC         GTCTCCTGGACTGTGGCATT
  2    laminin α2 (568 bp)   GenBank: XM_219866           TACCAAAGGCATTGCTTTCC         TGCACACGTCTCACAAGACA
  3    laminin α3 (678 bp)   GenBank: NM_173306           GGATGCCTCCAAGGACTACA         TTCTCTTTGGGTGGCTCTG
  4    laminin α4 (560 bp)   GenBank: NM_001107635        GACACGTGACCGACATGAAC         GGCCTGGTTAATGGATTCCT
  5    laminin α5 (622 bp)   GenBank: NM_001191609        GAAGCTGGCTCTTGTCATCC         GAAAGAGGTCAGGGGAGGTC
  6    laminin β1 (589 bp)   GenBank: NM_001106721        GAGCGGTCTTCTGACTTTGG         CAAAGTGACACGAGCTGGAA
  7    laminin β2 (666 bp)   GenBank: NM_012974           CCTTGGATGTACCTGGCTGT         TGTCTCCCAGTGTGTGAAGC
  8    laminin β3 (692 bp)   GenBank: NM_001100841        GGTTGCTAGATGCCAAGAGC         CCTGATCATTTGCCTGGTCT
  9    laminin γ1 (650 bp)   GenBank: NM_053966           AAGTGCCTGCCTTTCTTCAA         GAGCCATCTCTCTGCTCCAC
  10   laminin γ2 (639 bp)   GenBank: NM_001100640        GGCAGAGCCTGTCTTTTGAC         CCTCCTCTGTCTCAGGCATC
  11   laminin γ3 (597 bp)   GenBank: NM_001107830        CGAAGACCCTGCTAGCTGAC         CCTCCAGCTGCCTTAGTTTG

###### 

Primary antibodies

  Antigen                       Immunized animal   Dilution factor   Supplier
  ----------------------------- ------------------ ----------------- ------------------------------------------
  mouse laminin (LSL-LB-1013)   Rabbit             1:1600            Cosmo Bio, Tokyo, Japan
  human laminin α1 (H-300)      Rabbit             1:25              Santa Cruz Biotechnology, Santa Cruz, CA
  mouse laminin α3 (M-20)       Goat               1:25              Santa Cruz Biotechnology
  human laminin α4 (V-20)       Goat               1:25              Santa Cruz Biotechnology
  human LHβ                     Goat               1:100             Santa Cruz Biotechnology
  rat GH                        Goat               1:400             R&D Systems, Minneapolis, MN
  human TSHβ                    Mouse              1:800             Merck KGaA, Darmstadt, Germany
  synthetic PRL                 Mouse              1:800             QED Bioscience, San Diego, CA
  human 17-39-ACTH              Mouse              1:1600            EMD Millipore, Billerica, MA
  human desmin                  Mouse              1:100             DAKO, Glostrup, Denmark
  ovine LHβ                     Rabbit             1:6400            Advance, Tokyo, Japan

GH, growth hormone; LHβ, luteinizing hormone β subunit; TSHβ, thyroid-stimulating hormone β subunit; PRL, prolactin hormone; ACTH, adrenocorticotropic hormone.
